Isolated hepatic perfusion with extracorporeal oxygenation using hyperthermia TNF alpha and melphalan: Swedish experience.

Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer

Volumn 147, Issue , 1998, Pages 120-126

  Hafstrom L ^a   Naredi, P ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; MELPHALAN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL TRIAL; EXTRACORPOREAL OXYGENATION; HUMAN; HYPERTHERMIC THERAPY; LIVER TUMOR; METASTASIS; METHODOLOGY; MORTALITY; PHASE 1 CLINICAL TRIAL; REGIONAL PERFUSION; SURVIVAL RATE; SWEDEN; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS, ALKYLATING; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; EXTRACORPOREAL MEMBRANE OXYGENATION; HUMANS; HYPERTHERMIA, INDUCED; LIVER NEOPLASMS; MELPHALAN; SURVIVAL RATE; SWEDEN; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

MLCS; MLOWN;

EID: 0031616199     PISSN: 00800015     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-3-642-80460-1_12     Document Type: Article

References (0)